Total Payments
$2,532
2024 Payments
$68.43
Companies
16
Transactions
93
Medicare Patients
4,002
Medicare Billing
$587,752
Payment Breakdown by Category
Food & Beverage$2,492 (98.4%)
Education$39.95 (1.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,492 | 92 | 98.4% |
| Education | $39.95 | 1 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $624.91 | 17 | $0 (2020) |
| Gilead Sciences, Inc. | $462.12 | 12 | $0 (2021) |
| ViiV Healthcare Company | $426.41 | 16 | $0 (2024) |
| ABBVIE INC. | $211.95 | 7 | $0 (2024) |
| Merck Sharp & Dohme LLC | $171.85 | 11 | $0 (2023) |
| Melinta Therapeutics, LLC | $168.63 | 9 | $0 (2021) |
| TETRAPHASE PHARMACEUTICALS, INC. | $126.74 | 5 | $0 (2019) |
| PFIZER INC. | $85.12 | 5 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $68.41 | 2 | $0 (2019) |
| Janssen Biotech, Inc. | $44.72 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $68.43 | 3 | ABBVIE INC. ($39.70) |
| 2023 | $277.93 | 9 | ViiV Healthcare Company ($162.52) |
| 2022 | $76.54 | 4 | ViiV Healthcare Company ($60.85) |
| 2021 | $148.21 | 8 | Melinta Therapeutics, LLC ($58.10) |
| 2020 | $221.14 | 5 | Allergan, Inc. ($160.03) |
| 2019 | $1,019 | 34 | Allergan Inc. ($272.02) |
| 2018 | $633.64 | 27 | Gilead Sciences, Inc. ($179.77) |
| 2017 | $87.14 | 3 | Allergan Inc. ($63.81) |
All Payment Transactions
93 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/14/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE, AVYCAZ | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/13/2024 | ABBVIE INC. | AVYCAZ (Drug), TEFLARO, DALVANCE | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/08/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $28.73 | General |
| Category: HIV | ||||||
| 11/09/2023 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: HIV | ||||||
| 08/28/2023 | Smith+Nephew, Inc. | REGRANEX (Drug), COLLAGENASE SANTYL | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Pharma Products | ||||||
| 08/17/2023 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/04/2023 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/19/2023 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $33.87 | General |
| Category: HIV | ||||||
| 06/15/2023 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $113.00 | General |
| Category: HIV | ||||||
| 06/14/2023 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO, DIFICID | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/10/2023 | La Jolla Pharmaceutical Company | XERAVA (Drug) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: TETRACYCLINE CLASS ANTIBACTERIAL | ||||||
| 04/28/2023 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/27/2022 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: HIV | ||||||
| 03/07/2022 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: HIV | ||||||
| 02/02/2022 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: HIV | ||||||
| 01/06/2022 | La Jolla Pharmaceutical Company | XERAVA (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: TETRACYCLINE CLASS ANTIBACTERIAL | ||||||
| 12/23/2021 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: VACCINES | ||||||
| 11/28/2021 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: HIV | ||||||
| 11/17/2021 | Melinta Therapeutics, LLC | Orbactiv (Drug), Vabomere | Food and Beverage | In-kind items and services | $26.74 | General |
| Category: ANTIBIOTICS | ||||||
| 10/06/2021 | Melinta Therapeutics, LLC | Kimyrsa (Drug), Orbactiv, Vabomere | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: ANTIBIOTICS | ||||||
| 10/06/2021 | Merck Sharp & Dohme Corporation | PIFELTRO (Drug), ISENTRESS, DIFICID | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/26/2021 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $17.20 | General |
| 06/16/2021 | Melinta Therapeutics, LLC | Vabomere (Drug), Orbactiv | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: ANTIBIOTICS | ||||||
| 06/02/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.81 | General |
| 02/13/2020 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $24.31 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 946 | 1,275 | $524,485 | $118,484 |
| 2022 | 4 | 895 | 1,577 | $532,078 | $141,617 |
| 2021 | 5 | 938 | 1,189 | $537,818 | $139,438 |
| 2020 | 6 | 1,223 | 1,746 | $687,378 | $188,213 |
Total Patients
4,002
Total Services
5,787
Medicare Billing
$587,752
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 523 | 560 | $352,868 | $74,527 | 21.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 213 | 364 | $87,066 | $21,645 | 24.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 114 | 144 | $49,498 | $13,349 | 27.0% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 62 | 173 | $24,753 | $6,749 | 27.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 34 | 34 | $10,300 | $2,214 | 21.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 465 | 498 | $292,292 | $76,531 | 26.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 307 | 861 | $176,793 | $47,957 | 27.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 111 | 201 | $59,185 | $15,950 | 26.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 17 | $3,808 | $1,179 | 31.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 558 | 641 | $400,599 | $102,989 | 25.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 233 | 341 | $77,977 | $19,705 | 25.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 69 | 89 | $28,655 | $7,496 | 26.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 59 | 99 | $22,242 | $7,067 | 31.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 19 | 19 | $8,345 | $2,180 | 26.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 594 | 700 | $432,441 | $119,358 | 27.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 404 | 731 | $163,744 | $44,460 | 27.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 123 | 160 | $51,360 | $13,951 | 27.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 74 | 125 | $28,062 | $7,535 | 26.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 13 | 13 | $6,093 | $1,482 | 24.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 15 | 17 | $5,678 | $1,428 | 25.1% |
About Dr. Saba Khokhar, MD
Dr. Saba Khokhar, MD is a Internal Medicine healthcare provider based in Taunton, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/07/2008. The National Provider Identifier (NPI) number assigned to this provider is 1518133602.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Saba Khokhar, MD has received a total of $2,532 in payments from pharmaceutical and medical device companies, with $68.43 received in 2024. These payments were reported across 93 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($2,492).
As a Medicare-enrolled provider, Khokhar has provided services to 4,002 Medicare beneficiaries, totaling 5,787 services with total Medicare billing of $587,752. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine, Infectious Disease
- Location Taunton, MA
- Active Since 05/07/2008
- Last Updated 02/02/2026
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1518133602
Products in Payments
- AVYCAZ (Drug) $517.24
- Biktarvy (Drug) $234.01
- TEFLARO (Drug) $167.69
- DOVATO (Drug) $166.94
- CABENUVA (Biological) $151.25
- Mavyret (Drug) $134.73
- Xerava (Drug) $126.74
- ISENTRESS (Drug) $97.95
- Baxdela (Drug) $95.34
- JULUCA (Drug) $73.92
- PIFELTRO (Drug) $73.90
- XARELTO (Drug) $68.41
- PREVNAR - 13 (Biological) $48.91
- Symtuza (Drug) $44.72
- Orbactiv (Drug) $41.93
- XERAVA (Drug) $36.97
- TRIUMEQ (Drug) $34.30
- SMARTVEST (Device) $26.05
- Arikayce (Drug) $24.31
- STIOLTO (Drug) $23.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Taunton
Dr. Alexey Knyazhitskiy, M.d, M.D
Internal Medicine — Payments: $60,463
Internal Medicine $60,463
Anne Bauman, M.d, M.D
Internal Medicine — Payments: $7,541
Internal Medicine $7,541
Priti Patel, Md, MD
Internal Medicine — Payments: $3,983
Internal Medicine $3,983
Raanan Gilboa, Md, MD
Internal Medicine — Payments: $2,720
Internal Medicine $2,720
Yun Xia, Md, MD
Internal Medicine — Payments: $1,932
Internal Medicine $1,932
Cristina Cellurale, M.d, M.D
Internal Medicine — Payments: $1,197
Internal Medicine $1,197